Fig. 2
From: SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas
SLC39A1 expression is associated with prognosis in patients with glioma. (a, b, c) Kaplan–Meier analyses of patients with glioma (a), LGG (b) or HGG (c) in different expression level of SLC39A1. The red curve represents high expression and the blue curve represents low expression. P < 0.05 indicates a significant difference. d, e, f ROC (Receiver operator characteristic curve) analysis of SLC39A1 in patients with glioma (d), LGG (e) or HGG (f). AUC area under the curve